Free Trial

Erasca (ERAS) 10K Form and Latest SEC Filings 2026

Erasca logo
$10.46 +0.08 (+0.77%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$10.22 -0.24 (-2.25%)
As of 04:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Erasca SEC Filings & Recent Activity

Erasca (NASDAQ:ERAS) has submitted 222+ documents to the U.S. Securities and Exchange Commission (SEC) since 2019. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Erasca's financial statements. The most recent filing was a Form SCHEDULE 13G/A submitted on May 12, 2026.

Form 4
Erasca, Inc. Reports Ownership Change on Apr. 3, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Erasca Files Current Report on May. 11, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Erasca Files Quarterly Report on May. 11, 2026

The 10-Q contains Erasca's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Erasca SEC Filing History

Browse Erasca's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/12/2026 5:24 PM
Erasca (1761918) Subject
SUVRETTA CAPITAL MANAGEMENT, LLC (1569064) Filed by
Form SCHEDULE 13G/A
05/11/2026 3:13 PM
Erasca (1761918) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2026 3:05 PM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/28/2026 3:40 PM
Erasca (1761918) Filer
Form DEF 14A
04/28/2026 3:42 PM
Erasca (1761918) Filer
Form DEFA14A
04/28/2026 3:49 PM
Erasca (1761918) Filer
Form ARS
04/27/2026 3:17 PM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2026 7:31 AM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2026 8:10 AM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2026 4:20 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144/A
04/15/2026 4:06 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2026 8:00 AM
Erasca (1761918) Issuer
Garner Ebun (1364554) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 1:19 PM
Erasca (1761918) Subject
Garner Ebun (1364554) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/16/2026 1:38 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2026 8:00 AM
Erasca (1761918) Issuer
Morris Shannon (1973527) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2026 4:38 PM
Erasca (1761918) Subject
Morris Shannon (1973527) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 1:27 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/17/2026 9:28 AM
Erasca (1761918) Subject
T. Rowe Price Investment Management, Inc. (1897612) Filed by
Form SCHEDULE 13G/A
01/30/2026 8:00 AM
Erasca (1761918) Issuer
Garner Ebun (1364554) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2026 8:01 AM
Erasca (1761918) Issuer
Varney Michael David (1638647) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2026 8:02 AM
Erasca (1761918) Issuer
Morris Shannon (1973527) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2026 8:04 AM
Chacko David M. (1871801) Reporting
Erasca (1761918) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2026 8:05 AM
Erasca (1761918) Issuer
Lim Jonathan E (1283290) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2026 4:10 PM
Erasca (1761918) Filer
Form 424B5
01/22/2026 4:12 PM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/20/2026 3:05 PM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2026 9:43 AM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2026 3:30 PM
Erasca (1761918) Subject
Paradigm Biocapital Advisors LP (1855655) Filed by
Form SCHEDULE 13G
01/12/2026 7:02 AM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2026 8:20 PM
Erasca (1761918) Issuer
Garner Ebun (1364554) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2026 2:58 PM
Erasca (1761918) Subject
Garner Ebun (1364554) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2026 8:00 AM
Casdin Alexander W. (1455228) Reporting
Erasca (1761918) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 8:00 AM
Erasca (1761918) Issuer
Start Valerie Denise Harding (1652037) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 8:00 AM
Erasca (1761918) Issuer
Multani Pratik S (1586894) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 8:00 AM
Erasca (1761918) Issuer
LIU JEAN I (1241357) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2026 8:00 AM
Bristol James Arthur (1715153) Reporting
Erasca (1761918) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2025 7:11 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2025 11:59 AM
Erasca (1761918) Subject
Logos Global Management LP (1792126) Filed by
Form SCHEDULE 13G/A
11/12/2025 3:09 PM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2025 2:43 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2025 3:21 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
What is “gold skimming”? (Ad)

Former $900 million hedge fund manager Larry Benedict has developed a strategy he calls Gold Skimming - a way to target cash payouts from gold markets without buying a single ounce, mining stock, or ETF. With a reported 73% win rate across 19 trades and potential payouts of $2,975, $3,781, and $6,786 in a single day, Benedict has put together a free step-by-step walkthrough showing how it works whether gold climbs or pulls back.tc pixel

Watch the free walkthrough and see how Gold Skimming works today
08/24/2025 11:15 PM
Erasca (1761918) Filer
Form EFFECT
08/15/2025 2:21 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2025 12:10 PM
Erasca (1761918) Subject
Frazier Life Sciences Public Fund, L.P. (1863769) Filed by
Form SCHEDULE 13G/A
08/14/2025 11:12 AM
Erasca (1761918) Subject
T. Rowe Price Investment Management, Inc. (1897612) Filed by
Form SCHEDULE 13G/A
08/13/2025 7:14 PM
Erasca (1761918) Subject
SUVRETTA CAPITAL MANAGEMENT, LLC (1569064) Filed by
Form SCHEDULE 13G
08/12/2025 3:45 PM
Erasca (1761918) Filer
Form S-3
Registration statement under Securities Act of 1933  
06/26/2025 4:04 PM
Erasca (1761918) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2025 3:24 PM
Bristol James Arthur (1715153) Reporting
Erasca (1761918) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 3:25 PM
Erasca (1761918) Issuer
Multani Pratik S (1586894) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 3:26 PM
Erasca (1761918) Issuer
Start Valerie Denise Harding (1652037) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 3:27 PM
Erasca (1761918) Issuer
Hambleton Julie (1578771) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 3:27 PM
Erasca (1761918) Issuer
LIU JEAN I (1241357) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025 3:28 PM
Erasca (1761918) Issuer
Varney Michael David (1638647) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025 2:16 PM
Erasca Foundation (1973524) Reporting
Erasca (1761918) Subject
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025 8:44 AM
Erasca (1761918) Subject
Frazier Life Sciences Public Fund, L.P. (1863769) Filed by
Form SCHEDULE 13G/A
(Data available from 1/1/2016 forward)

Erasca SEC Filings - Frequently Asked Questions

Erasca (ERAS) has submitted 222+ filings to the SEC since 2019. You can browse the complete history or filter by form type using the tools above.

Erasca's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Erasca's financial statements page.

The most recent filing was a Form SCHEDULE 13G/A submitted on May 12, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NASDAQ:ERAS) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners